BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26390560)

  • 1. [THE ROLE OF KALLIKREIN-KININ AND RENIN- ANGIOTENSIN SYSTEM IN THE PATHOGENESIS OF PROSTATE CANCER].
    Kogan MI; Chernogubova EA; Chibichjan MB; Macionis AJ; Povilajtite PJ; Matishov DG
    Urologiia; 2015; (3):50-4. PubMed ID: 26390560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for activation of the renin-angiotensin system in the human prostate: increased angiotensin II and reduced AT(1) receptor expression in benign prostatic hyperplasia.
    Dinh DT; Frauman AG; Somers GR; Ohishi M; Zhou J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2002 Feb; 196(2):213-9. PubMed ID: 11793373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kallikrein-kinin and renin-angiotensin systems in the kidney of an African lungfish, Protopterus annectens.
    Masini MA; Napoli L; Sturla M; Uva B
    Gen Comp Endocrinol; 1996 Jul; 103(1):93-100. PubMed ID: 8812341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of angiotensin-converting enzyme and angiotensin ii receptors of the second type in the pathogenesis of proliferative diseases of the prostate].
    Chibichyan MB; Chernogubova EA; Avetyan AV; Lapteva TO; Pavlenko IA; Kogan MI
    Urologiia; 2022 Mar; (1):5-10. PubMed ID: 35274851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appearance of angiotensin II expression in non-basal epithelial cells is an early feature of malignant change in human prostate.
    Louis SN; Wang L; Chow L; Rezmann LA; Imamura K; MacGregor DP; Casely D; Catt KJ; Frauman AG; Louis WJ
    Cancer Detect Prev; 2007; 31(5):391-5. PubMed ID: 18031950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Selected components of the kallikrein-kinin system and of the renin-angiotensin-aldosterone system in offspring of parents with hypertension].
    Marzecka J
    Ann Acad Med Stetin; 1996; 42():123-38. PubMed ID: 9199117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems.
    Su JB
    J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):319-28. PubMed ID: 23386283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anti-thrombotic mechanisms mediated by Mas receptor as result of balanced activities between the kallikrein/kinin and the renin-angiotensin systems.
    Fang C; Schmaier AH
    Pharmacol Res; 2020 Oct; 160():105096. PubMed ID: 32712319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards understanding the kallikrein-kinin system: insights from measurement of kinin peptides.
    Campbell DJ
    Braz J Med Biol Res; 2000 Jun; 33(6):665-77. PubMed ID: 10829095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of thrombospondin-1 in benign prostatic hyperplasia and prostatic intraepithelial neoplasia is decreased in prostate cancer.
    Vallbo C; Wang W; Damber JE
    BJU Int; 2004 Jun; 93(9):1339-43. PubMed ID: 15180634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of the kallikrein-kinin and renin-angiotensin-aldosterone systems in the development of hypertension in glomerulonephritis].
    Riabov SI; Kucher AG; Kotovoĭ IuO; Kaiukov IG
    Klin Med (Mosk); 1990 Dec; 68(12):22-5. PubMed ID: 2084330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STEAP1 is overexpressed in prostate cancer and prostatic intraepithelial neoplasia lesions, and it is positively associated with Gleason score.
    Gomes IM; Arinto P; Lopes C; Santos CR; Maia CJ
    Urol Oncol; 2014 Jan; 32(1):53.e23-9. PubMed ID: 24239460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the renal kallikrein-kinin system in diabetic nephropathy.
    Riad A; Zhuo JL; Schultheiss HP; Tschöpe C
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):22-6. PubMed ID: 17143067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
    De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
    Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia.
    Nassis L; Frauman AG; Ohishi M; Zhuo J; Casley DJ; Johnston CI; Fabiani ME
    J Pathol; 2001 Dec; 195(5):571-9. PubMed ID: 11745693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regulation of prostatic growth, pathogenesis of prostatic adenoma and cancer].
    Darenkov AF; Evdokimov VV; Alfimov AE
    Vestn Ross Akad Med Nauk; 1994; (11):50-9. PubMed ID: 7530531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin and the kallikrein-kinin systems.
    Campbell DJ
    Int J Biochem Cell Biol; 2003 Jun; 35(6):784-91. PubMed ID: 12676165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic control in rats with overactivity of tissue renin-angiotensin or kallikrein-kinin system.
    Ribeiro JM; Santos RA; Pesquero JB; Bader M; Krieger EM
    Regul Pept; 2005 Jul; 129(1-3):155-9. PubMed ID: 15927711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kallikrein-kinin and the renin-angiotensin systems have a multilayered interaction.
    Schmaier AH
    Am J Physiol Regul Integr Comp Physiol; 2003 Jul; 285(1):R1-13. PubMed ID: 12793984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-talk of the renin-angiotensin and kallikrein-kinin systems.
    Shen B; El-Dahr SS
    Biol Chem; 2006 Feb; 387(2):145-50. PubMed ID: 16497145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.